Gamida Cell Other Current Liabilities

Gamida Cell (GMDA) currently reports a other current liabilities of $13M as of March 2024. That compares with $16M in the prior-year period — down 17.5% year over year. Use the charts on this page to explore Gamida Cell's other current liabilities history and peer comparisons.

Gamida Cell's other current liabilities decreased from $16M to $13M — a 17.5% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gamida Cell reported $13M in other current liabilities as of March 2024. That compares with $16M in the prior-year period — down 17.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gamida Cell, and consider following GMDA for alerts when major investors trade the stock.

Gamida Cell is classified in the Healthcare sector. On other current liabilities, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GMDA with unrelated industries.